By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Mersana Therapeutics, Inc. 

840 Memorial Drive
2nd Floor
Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-498-0020 Fax: n/a



Company News
Booming Mersana Nabs Another $33 Million for a Total Take of $120 Million+ 6/16/2016 6:40:48 AM
Takeda (TKPYY) Wagers $1 Billion+ More on Mersana Therapeutics' Antibody Program 2/3/2016 7:50:49 AM
Mersana Therapeutics' Lead Immunoconjugate Continues To Demonstrate Complete Tumor Regressions In Multiple HER2-Expressing Breast Cancer Tumor Models 12/14/2015 7:42:20 AM
Mersana Therapeutics To Present Poster At The 2015 San Antonio Breast Cancer Symposium 12/1/2015 10:07:07 AM
Mersana Therapeutics To Present At World ADC San Diego 10/16/2015 8:11:32 AM
Mersana Therapeutics' Lead Fleximer Immunoconjugate Demonstrates Potent Activity In Low HER2-Expressing Tumor Models 4/17/2015 2:51:12 PM
Mersana Therapeutics To Present Late-Breaking Poster At American Association for Cancer Research Annual Meeting 2015 4/15/2015 7:16:31 AM
Mersana Therapeutics Nabs $35 Million And A New CEO 3/2/2015 10:44:14 AM
Mersana Therapeutics, Inc., Takeda Pharmaceutical Co. Ltd. (TKPYY) Expand Antibody-Drug Pact By $300 Million 1/12/2015 6:17:41 AM
Mersana Therapeutics, Inc. And Takeda Pharmaceutical Co. Ltd. (TKPYY) Enter Commercial License Agreement For Novel Fleximer┬« Antibody-Drug Conjugate 10/27/2014 10:47:56 AM